Factors Associated With Relapse After Emergency Department Treatment for Acute Asthma,☆☆,

Presented in part at the American College of Emergency Physicians Research Forum, San Diego, March 1994.
https://doi.org/10.1016/S0196-0644(95)70230-XGet rights and content

Abstract

Study objective: The rate of relapse after emergency department treatment for acute asthma is high. Most studies on this subject were performed before the recent recommendations for routine use of corticosteroids and followed the patients for 10 or fewer days. We sought to evaluate relapse following ED treatment for acute asthma over a longer period, focusing particularly on the relationship between steroid use and outpatient follow-up visits. Design: A prospective study in which we followed patients for 21 days after discharge to determine their relapse rate (unscheduled return for asthma treatment) and compliance with scheduled outpatient appointments. Setting: University-affiliated county hospital ED. Participants: One hundred four adult asthmatic patients discharged from our ED after treatment under a standardized protocol. Results: Follow-up was performed for 91 patients (88%). There was no difference in the posttreatment forced expiratory volume at 1 second between those who relapsed (55.2%) and those who did not (57.8%; NS). Twenty-three patients (25.3%) relapsed within 3 weeks of discharge. Ninety-one percent of relapses occurred before the patients saw their primary care physician. Those who relapsed had a history of previous ED visits and hospitalizations. There was no difference in theophylline levels or history of cigarette use. Patients who relapsed within 3 days had higher eosinophil counts. Conclusion: Even with routine use of oral corticosteroids, a high percentage of patients relapse after ED treatment for acute asthma. Patients who relapse have a greater number of recent ED visits and so should be targeted for more aggressive management of their asthma. [Emerman CL, Cydulka RK: Factors associated with relapse after emergency department treatment for acute asthma. Ann Emerg Med July 1995;26:6-11.]

Section snippets

INTRODUCTION

Patients who experience relief of dyspnea after emergency department treatment may relapse after discharge. Several investigators have devised criteria to distinguish patients who can be discharged safely from those who are likely to continue to have symptoms of asthma. Early studies focused on changes in pulmonary function during ED treatment for asthma, specifying the degree of improvement in pulmonary function needed to discharge the patient successfully.1, 2 Some investigators have failed

MATERIALS AND METHODS

Our study was conducted in the ED of MetroHealth Medical Center— a large, urban, county-owned, university-affiliated ED—from February 1992 through June 1993. Patients were included in the study if they presented to the ED with acute asthma manifested as dyspnea, cough, or wheezing and a 1-second initial forced expiratory volume (FEV1) less than 70% of the predicted normal value. Adult patients between the ages of 18 and 50 years were eligible for the study if they had history of asthma.

RESULTS

One hundred forty-five patients were enrolled initially in the study; 104 were discharged from the ED, and 41 were admitted to the hospital. Follow-up data were available for 91 patients (88%). There was no significant difference between patients who were followed and those who were lost to follow-up in age, pretreatment and posttreatment FEV1, gender, or medication use. The 27 male and 64 female patients had a mean age of 35.7±13.1 years. Of the 91 patients, 28.9% were cigarette smokers and

DISCUSSION

Identifying patients at risk for relapse and devising methods for minimizing the risk of relapse have been the subjects of many studies. Early investigators focused on using spirometric criteria to identify patients at risk for relapse. Nowak et al1 studied 59 patients discharged from the ED after standardized therapy that did not include corticosteroids and found that those discharged with subsequent persistent dyspnea had a lower FEV1 (1.19±.65 L) than patients discharged successfully

CONCLUSION

Despite oral corticosteroid therapy, 25% of patients treated in the ED for asthma relapsed within 3 weeks. Pulmonary function testing was not useful in identifying patients at risk for relapse. Those who relapsed were characterized by history of frequent ED visits. Patients who relapsed early were characterized by eosinophilia. The timing of relapse does not seem to correlate with the termination of corticosteroid therapy. The patients at highest risk of relapse may benefit from more aggressive

References (20)

There are more references available in the full text version of this article.

Cited by (62)

  • Rates and correlates of relapse following ED discharge for acute asthma: A Canadian 20-site prospective cohort study

    2015, Chest
    Citation Excerpt :

    It is likely that the use of these medications is confounded by severity; sicker patients with more severe chronic asthma are treated with more aggressive therapy. Finally, a failure to identify associations between relapse and several widely cited factors was important.9‐11 Most notably, the role of pulmonary flow measures has been a controversial area in the literature.19‐22

  • A randomized controlled trial of self-management education for asthma patients in the emergency department

    2011, Annals of Emergency Medicine
    Citation Excerpt :

    This explanation is consistent with outcomes of other reports that showed better quality of life and fewer ED visits for patients who stopped smoking and decreased exposure to environmental smoke.41,42 Regarding the repeated ED outcome, our results confirm results of other studies that reported greater prevalence of ED visits among patients with previous ED visits and lack of medical follow-up; the latter issue was approximated in our study by self-reported difficult access to outpatient care.4,6,8,43,44 However, unlike other researchers we did not find that hospitalization for asthma was associated with more subsequent ED visits.

  • Pitfalls in the Evaluation of Shortness of Breath

    2010, Emergency Medicine Clinics of North America
    Citation Excerpt :

    The factors associated with asthma relapse were a history of frequent ED visits over the previous year, use of a home nebulizer, multiple asthma triggers, and symptoms lasting for more than a day. Lack of a regular primary-care physician was also associated with a higher incidence of relapse.41 In the treatment and assessment of the asthmatic, it is crucial to be aware of the criteria for severe asthma, and screening patients for predictors of near-fatal and fatal asthma attacks should be part of the discharge planning for every patient who presents to the ED with asthma.

View all citing articles on Scopus

From the Department of Emergency Medicine, MetroHealth Medical Center, Department of Surgery, Case Western Researve University, Cleveland, Ohio.

☆☆

Address for reprints: Charles L Emerman, MD, FACEP, Department of Emergency Medicine, S1-203, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, Ohio 44109

Reprint no. 47/1/65119

View full text